Idexx Laboratories, Inc. Earnings

Idexx Laboratories, Inc.’s revenue jumped 10.55% since last year same period to $1109.46Mn in the Q2 2025. On a quarterly growth basis, Idexx Laboratories, Inc. has generated 11.12% jump in its revenue since last 3-months.

Idexx Laboratories, Inc.’s net profit jumped 44.61% since last year same period to $293.99Mn in the Q2 2025. On a quarterly growth basis, Idexx Laboratories, Inc. has generated 21.14% jump in its net profits since last 3-months.

Idexx Laboratories, Inc.’s net profit margin jumped 30.81% since last year same period to 26.5% in the Q2 2025. On a quarterly growth basis, Idexx Laboratories, Inc. has generated 9.02% jump in its net profit margins since last 3-months.

Idexx Laboratories, Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 53.52.

Idexx Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.13 - a -5.15% fall from last quarter’s estimates.

Idexx Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 3.13.

Idexx Laboratories, Inc.’s earning per share (EPS) jumped 15.89% since last year same period to 3.5 in the Q2 2025. This indicates that the Idexx Laboratories, Inc. has generated 15.89% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Idexx Laboratories, Inc.’s return on assets (ROA) stands at 0.23.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Idexx Laboratories, Inc.’s return on equity (ROE) stands at 0.65.